Literature DB >> 1704930

Epitope mapping and characterization of the infectious hematopoietic necrosis virus glycoprotein, using fusion proteins synthesized in Escherichia coli.

L Xu1, D V Mourich, H M Engelking, S Ristow, J Arnzen, J C Leong.   

Abstract

A characterization of the antigenic determinants (epitopes) of the glycoprotein (G) of infectious hematopoietic necrosis virus was made by expressing different regions of the G gene in Escherichia coli. A cDNA copy of the G gene was divided into four fragments by TaqI digestion, and the fragments were subcloned into pATH vectors, placing the expression of each G gene fragment under control of the trpE promoter. The resulting plasmids, pXL2, pXL3, and pXL7, encoded trpE-G fusion proteins subsequently detected with anti-infectious hematopoietic necrosis virus sera by Western immunoblots. A comparison of reactivities of the fusion proteins encoded by these plasmids was made by Western immunoblot and radioimmunoassay with a number of anti-G specific monoclonal antibodies (MAbs). The nonneutralizing MAb 136J reacted with the trpE-G fusion protein encoded by pXL3 and fusion proteins encoded by plasmids p52G and p618G, which were described in previous studies (R. D. Gilmore, Jr., H. M. Engelking, D. S. Manning, and J. C. Leong. Bio/Technology 6:295-300, 1988). Another nonneutralizing MAb, 2F, bound to the pXL3 fusion protein, and the neutralizing MAb RB/B5 recognized the pXL7 fusion protein. All fusion proteins were tested as vaccines in rainbow trout fry. Although significant protection was induced by all fusion proteins, the pXL3 fusion protein was most effective as a vaccine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704930      PMCID: PMC239947     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Structural proteins of two salmonid rhabdoviruses.

Authors:  P E McAllister; R R Wagner
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein.

Authors:  I Seif; P Coulon; P E Rollin; A Flamand
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.

Authors:  W Keil; R R Wagner
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Physicochemical properties of RNA of salmonid hematopoietic necrosis virus (Oregon strain).

Authors:  B B McCain; J L Fryer; K S Pilcher
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  A rapid boiling method for the preparation of bacterial plasmids.

Authors:  D S Holmes; M Quigley
Journal:  Anal Biochem       Date:  1981-06       Impact factor: 3.365

Review 8.  The viral diseases of fish: a review through 1978. Part 1: Diseases of proven viral etiology.

Authors:  K S Pilcher; J L Fryer
Journal:  Crit Rev Microbiol       Date:  1980       Impact factor: 7.624

9.  Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.

Authors:  B Dietzschold; W H Wunner; T J Wiktor; A D Lopes; M Lafon; C L Smith; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.

Authors:  J Shine; L Dalgarno
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

View more
  7 in total

1.  Caulobacter crescentus synthesizes an S-layer-editing metalloprotease possessing a domain sharing sequence similarity with its paracrystalline S-layer protein.

Authors:  Elizabeth Umelo-Njaka; Wade H Bingle; Faten Borchani; Khai D Le; Peter Awram; Theo Blake; John F Nomellini; John Smit
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

Review 2.  The glycoprotein G of rhabdoviruses.

Authors:  J M Coll
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  Inhibition of an Aquatic Rhabdovirus Demonstrates Promise of a Broad-Spectrum Antiviral for Use in Aquaculture.

Authors:  Bethany F Balmer; Rachel L Powers; Ting-Hu Zhang; Jihye Lee; Frederic Vigant; Benhur Lee; Michael E Jung; Maureen K Purcell; Kevin Snekvik; Hector C Aguilar
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

4.  Linker mutagenesis of the Caulobacter crescentus S-layer protein: toward a definition of an N-terminal anchoring region and a C-terminal secretion signal and the potential for heterologous protein secretion.

Authors:  W H Bingle; J F Nomellini; J Smit
Journal:  J Bacteriol       Date:  1997-02       Impact factor: 3.490

5.  Neutralization-resistant variants of infectious hematopoietic necrosis virus have altered virulence and tissue tropism.

Authors:  C H Kim; J R Winton; J C Leong
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Recombinant infectious hematopoietic necrosis virus and viral hemorrhagic septicemia virus glycoprotein epitopes expressed in Aeromonas salmonicida induce protective immunity in rainbow trout (Oncorhynchus mykiss).

Authors:  B Noonan; P J Enzmann; T J Trust
Journal:  Appl Environ Microbiol       Date:  1995-10       Impact factor: 4.792

7.  Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.

Authors:  M Alonso; D A Stein; E Thomann; H M Moulton; J C Leong; P Iversen; D V Mourich
Journal:  J Fish Dis       Date:  2005-07       Impact factor: 2.767

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.